His expertise spans Cardiac Rhythm Management, Electrophysiology, Coronary and Endovascular care, Vessel Closure, and Structural Heart.
Roger has held senior commercial roles at companies including Guidant, Boston Scientific, Abbott, and most recently Cardiva, where he served as Chief Commercial Officer prior to the company's acquisition in 2021.
Roger holds a Bachelor of Science in Biomedical Science, a Bachelor of Arts in Psychology, and a Master of Science in Cardiac Physiology, all from Ohio University.
